Investing

Medicine Man Denver announced it was terminating its deal with Schwazze and will look for new partners; it’s the second failed deal in as many months for Schwazze.

The SEC has filed charges against six people for allegedly defrauding more than 400 investors out of $25 million; the scheme supposedly took place between September 2017 and February 2019.

The SEC has ordered a halt to the High Times IPO after the company missed its annual report deadline in June; recent marketing material, however, suggests that fundraising efforts are still underway.

Collective Growth Corp., the new hemp investment and acquisition venture headed by veteran cannabis CEO Bruce Linton, raised $150 million in its recent IPO.

Brian Lannon, the co-founder and former CEO for Cannalysis, a California testing lab, has filed suit against the company over allegations of wrongful termination, fraudulent activities, and more.

Former NBA player Al Harrington has launched a business incubator program to help Black entrepreneurs enter the cannabis space.

Recent data released by the Maryland Medical Cannabis Commission shows that just 10 percent of the state’s cannabis industry investors are people of color.

Catharine Dockery is a founding partner of Vice Ventures, a venture capital fund that focuses on verticals that other investors typically avoid.

Peter Thiel’s Palantir was awarded a contract to build the government’s COVID-19 tracking database; Thiel is a major investor in Privateer Holdings and a prominent supporter of President Trump.

Cannabis businesses in North America are beginning to experience financial fallout from the ongoing coronavirus pandemic.

Chris Treville is the Co-Founder of GrowEx, a high-tech cannabis cultivation company focused on improving and innovating indoor growing systems.

Bruce Linton, the renowned former CEO of Canopy Growth, has launched a new company focusing on hemp and CBD investment opportunities.

Scott Goldie is the Chief Executive Officer of Goldenseed, a vertically and horizontally integrated California cannabis company.

The owners of a cannabis farm in Anacortes, Washington have been accused of defrauding investors of nearly five million dollars in an illegal Ponzi scheme.

Michael Catudal is a Managing Partner at Capital Business Collective, a private equity advisory that emphasizes unique ideas in the cannabis industry by helping connect investors with ripe opportunities.

Jon Trauben is a partner at Altitude Investment Management, an investment banking and asset fund management firm working directly in the cannabis space.

Recent surveying data suggests that investors are evenly split between whether or not they would ever invest in the cannabis space.

Multiple high-profile Rhode Islanders have announced investments into the state’s medical cannabis and industrial hemp industries.

Tech firm Flowhub has landed $23 million as part of its Series A funding round. The round was led by Evolv Ventures, a venture fund backed by Kraft Heinz, which is partly owned by Warren Buffett’s Berkshire Hathaway.

Colorado cannabis company Ebbu has been accused of violating Colorado investment laws by failing to properly disclose investor identities in its early fundraising rounds.

Cannabis mergers and acquisitions have made for some big stories this year — here’s an in-depth look at the strategies behind these moves, and an explanation of how you might use M&A to grow your own cannabis enterprise.

A $1 million private donation to the Oregon State University’s Global Hemp Innovation Center will fund research into hemp’s industrial applications and use in consumer goods and health products.

Meg Sanders is co-founder of the Canna Provisions Group — a boutique dispensary in Lee, Massachusetts — and co-owner of the successful MiNDFUL dispensary brand in Colorado.

The world’s first billionaire from the legal cannabis industry is reportedly Boris Jordan, chairman for Curaleaf.